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Abstract
Recent studies revealed that hemoglobin is expressed in some non-erythrocytes and it suppresses oxidative stress when
overexpressed. Oxidative stress plays a critical role in the pathogenesis of non-alcoholic steatohepatitis (NASH). This study
was designed to investigate whether hemoglobin is expressed in hepatocytes and how it is related to oxidative stress in
NASH patients. Analysis of microarray gene expression data revealed a significant increase in the expression of hemoglobin
alpha (HBA1) and beta (HBB) in liver biopsies from NASH patients. Increased hemoglobin expression in NASH was validated
by quantitative real time PCR. However, the expression of hematopoietic transcriptional factors and erythrocyte specific
marker genes were not increased, indicating that increased hemoglobin expression in NASH was not from erythropoiesis,
but could result from increased expression in hepatocytes. Immunofluorescence staining demonstrated positive HBA1 and
HBB expression in the hepatocytes of NASH livers. Hemoglobin expression was also observed in human hepatocellular
carcinoma HepG2 cell line. Furthermore, treatment with hydrogen peroxide, a known oxidative stress inducer, increased
HBA1 and HBB expression in HepG2 and HEK293 cells. Importantly, hemoglobin overexpression suppressed oxidative stress
in HepG2 cells. We concluded that hemoglobin is expressed by hepatocytes and oxidative stress upregulates its expression.
Suppression of oxidative stress by hemoglobin could be a mechanism to protect hepatocytes from oxidative damage in
NASH.
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Introduction
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver
disease closely associated with obesity and insulin resistance.
With the increasing prevalence of obesity worldwide, NAFLD is
becoming one of the most common liver diseases in adults and
children. The hepatic lesions of NAFLD range from simple
steatosis to nonalcoholic steatohepatitis (NASH), and to cirrhosis
[1–3]. NASH is characterized by macrosteatosis, hepatocyte
ballooning, and mixed lobular inflammation [4–8]. Although the
pathogenesis of NASH is not fully understood, several lines of
studies indicate that oxidative stress, an imbalance between the
production of reactive oxygen species and antioxidants, plays a
central role in the progression from simple steatosis to NASH
[9–13]. Increased oxidative stress and decreased antioxidant
enzymes such as glutathione peroxidase and superoxide dis-
mutase have been reported in NASH [14–16]. In some clinical
studies antioxidants are shown to have beneficial effects on the
livers of patients with NASH [17,18]. At present, liver biopsy
remains the golden standard for NASH diagnosis. Several
promising serum biomarkers such as cytokeratin 18 need to be
validated for non invasive diagnosis for NASH in large scale
clinical trials [19]. A recent proteomic study has shown that free
hemoglobin subunits a and b in serum are significantly increased
in NASH patients as compared to those with steatosis
[20,21]The source of free serum hemoglobin in serum is
unknown, but presumed to result from oxidative stress-induced
hemolysis.
Hemoglobin is a predominant component in erythrocytes and
functions as an oxygen transporter in blood. The major
hemoglobin form in adults is a tetramer consisting of two a- and
b-subunits (a2 b2), each of which contains a heme group [22,23].
Recently hemoglobin expression has been reported in non
erythrocytes including neurons [24–26], retinal cells [27,28],
alveolar cells [29–31], mesangial cells of the kidney [32], and
macrophages [33]. In alveolar cells, hemoglobin expression is
induced by hypoxia [29]. Hemoglobin overexpression in murine
MN9D [24] and SV40-MES13 [32] cells affects expression of
various genes involved in O2 homeostasis or suppresses oxidative
stress, respectively. The function and regulation of non-erythro-
cyte hemoglobin is not fully understood.
We report that hemoglobin is expressed in hepatocytes and is
increased in NASH. Oxidative stress upregulates hemoglobin
expression and hemoglobin overexpression suppresses oxidative
stress in HepG2 cells. These findings suggest that hemoglobin
plays a protective role in NASH.
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Elevated hemoglobin gene expression in NASH liver
biopsies
To identify differentially expressed genes in NASH, we analyzed
a recently published microarray dataset including 12 NASH
and 5 control samples. Compared to non-NASH controls, NASH
samples showed a significant increase in the expression of HBA1
and HBB genes (Table 1). However, the expression of transcrip-
tion factors for erythroid differentiation including GATA1, NFE2,
KLF1, and TAL1 did not increase. In addition, the expression of
other hemoglobin genes (HBD, HBE1, HBG2, HBQ1, and HBZ)
and erythrocyte specific marker genes [34,35] such as SPTA,
SPTB, GYPA, and ALAS2 did not show a significant increase,
suggesting that increased HBA1 and HBB expression in NASH
did not result from erythropoiesis, but from a different mechanism.
Increased HBA1 and HBB expression in NASH livers was
validated by qRT-PCR. A 6.7 and 7.9 fold increase in the relative
copy numbers were detected in NASH livers for HBA1 and HBB,
respectively (Fig. 1).
Detection of hemoglobin proteins in NASH liver biopsies
Immunofluorescence (IF) staining of the cryosections from
NASH biopsies were performed to examine the cellular distribu-
tion of HBA1 and HBB. As shown in Fig. 2, NASH liver biopsies
exhibited positive signals for HBA1 (Fig. 2A&B) and HBB
(Fig. 2C&D). Higher amplifications indicated that HBA1 and
HBB proteins were expressed in the cytoplasm of the hepatocytes
(Fig 2B &D). Radixin, specifically expressed in liver bile canaliculi
[36], was used to identify hepatocytes.
Detection of hemoglobin expression in HepG2 cells
To further confirm that hemoglobin proteins were expressed in
hepatocytes, expression of HBA1 and HBB was examined in the
HepG2 cell line. First, HBA1 and HBB mRNA expression in
HepG2 cells was examined using reverse transcription PCR. RNA
extracted from blood cells was used as a positive control. HBA1
Table 1. Increased HBA1 and HBB expression in NASH.
Gene Name Gene Symbol NASH Control NASH/Control P Value
Hemoglobin family
Hemoglobin, alpha 1 HBA1 112.3 29.83 3.77 0.023
Hemoglobin, beta HBB 151.2 41.63 3.63 0.030
Hemoglobin, delta HBD 0.28 2.59 0.11 0.141
Hemoglobin, epsilon 1 HBE1 7.78 8.64 0.90 0.367
Hemoglobin, gamma G HBG2 0.30 0.46 0.65 0.099
Hemoglobin, theta 1 HBQ1 0.48 0.31 1.57 0.269
Hemoglobin, zeta HBZ 1.12 0.82 1.37 0.084
Transcription factors for erythroid differentiation
GATA binding protein 1 (globin transcription factor 1) GATA1 8.69 18.99 0.46 0.000
Nuclear factor (erythroid-derived 2) NFE2 0.27 0.46 0.59 0.109
Kruppel-like factor 1 (erythroid) KLF1/EKLF 0.27 0.39 0.70 0.335
T-cell acute lymphocytic leukemia 1 TAL1/SCL 6.37 7.78 0.82 0.035
Erythroid cell markers
Aminolevulinate, delta-, synthase 2 ALAS2 0.55 0.69 0.80 0.214
Glycophorin A GYPA 11.97 21.95 0.55 0.000
Glycophorin B GYPB 0.17 0.19 0.86 0.830
Spectrin, beta, erythrocytic SPTB 0.39 0.33 1.19 0.703
Erythroid-associated factor ERAF 22.09 19.47 1.13 0.389
doi:10.1371/journal.pone.0024363.t001
Figure 1. Increased expression of HBA1 and HBB in NASH
livers. Quantitative real time PCR was performed with the same NASH
(n=12) and control (n=5) samples used for microarray analysis. GAPDH
was used as an endogenous control. Hemoglobin levels in controls
were normalized to 1. Data were expressed as Mean 6 SD. * and
** represent P,.05 and P,.01, respectively.
doi:10.1371/journal.pone.0024363.g001
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PCR products were sequenced and exhibited 100% match with
HBA1 (NM_000558) and HBB (NM_000518) mRNA sequences.
Consistent with a previous study in alveolar cells [30], qRT-PCR
showed that HBA1 expression is about 17 folds higher than HBB
(Data not shown). Next, western blotting was performed to
examine the expression of hemoglobin proteins in HepG2 cells.
HBA1 proteins were detected in HepG2 cells (Fig. 3B). The HBA1
band (about 17 Kd) appeared at the same molecular weight as that
from blood cells. Moreover, HBA1 signal was increased when
HepG2 cells were transfected with HBA1 expression plasmid
pIRES/HBA&HBB, demonstrating the HBA1 band detected in
HepG2 cells was HBA1 specific. However, we were unable to
detect HBB protein in HepG2 cells, probably because of the low
expression level as suggested by RT-PCR.
Upregulation of hemoglobin expression by oxidative
stress
Oxidative stress is known to be elevated in NASH and, as a
result, various stress responsive genes are up or down regulated. It
is of interest to test whether hemoglobin expression can be
regulated by oxidative stress. HepG2 cells were treated with
hydrogen peroxide, a commonly used inducer for oxidative
stress, and harvested for mRNA analysis and protein levels of
hemoglobin. As shown in Fig. 4A, HBA1 mRNA levels were
increased by H2O2 in a dose dependent manner at each time
point tested. Consistently, HBA1 protein was also increased by
H2O2 treatment as shown in Fig. 4B. Although HBB protein was
undetectable in HepG2 cells, HBB mRNA was also induced by
H2O2 treatment (Fig. 4C). Further, we tested if oxidative stress
can induce hemoglobin expression in other non-erythrocytes. As
shown in Fig. 4D, hemoglobin mRNA was also induced by H2O2
in human embryonic kidney HEK293 cells. In addition, we tested
if oxidative stress has any effects on the expression of GATA1, a
Figure 2. HBA1 and HBB expression in the hepatocytes of NASH livers. Immunofluorescence staining was performed on cryosections of
NASH liver biopsies. Radixin is expressed in liver bile canaliculi. Radixin staining was used to identify hepatocytes. Images were recorded with an
LSM510 beta laser scanning microscope (Zeiss). Cytoplasmic staining of HBA1 (A&B) and HBB (C&D) in hepatocytes of NASH livers were detected,
respectively. Bars in A&C: 50 mm, bars in B&D: 10 mm.
doi:10.1371/journal.pone.0024363.g002
Figure 3. Expression of HBA1 and HBB in HepG2 cells. A, HBA1
and HBB mRNA were detected by reverse transcription PCR. PCR
products were separated on 2% agrose gel and visualized with
ethidium bromide. PCR products were further confirmed by sequenc-
ing. B, HBA1 protein was detected by Western blot analysis. Whole cell
lysates from HepG2 cells transfected with control or HBA&HBB
expression plasmid were analyzed for HBA1 protein. Blood cells were
used as the positive control. Beta actin was probed as a loading control.
doi:10.1371/journal.pone.0024363.g003
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erythropoiesis. As shown in Fig. S1, H2O2 significantly decreased
the GATA1 expression.
Reduction of oxidative stress by hemoglobin
overexpression
As shown in Fig. 4, hemoglobin expression is inducible by
oxidative stress. Next we attempted to determine its function in
non-erythrocytes. Some oxidative stress inducible genes such as
heme oxygenase 1 (HMOX1) have anti-oxidative functions [37],
so we tested if hemoglobin overexpression had any effects on
oxidative stress. HepG2 cells were transfected with control or
pIRES/HBA&HBB plasmid expressing HBA1 and HBB for 48
hours and then treated with H2O2, followed by measuring
intracellular oxidative stress by flow cytometry. As shown in
Fig. 5A, in H2O2 treated cells, the histogram plot of hemoglobin
overexpression was shifted to the left, indicating reduction of
intracellular oxidative stress. Quantitative analyses of mean
fluorescence intensity showed a significant reduction of oxidative
stress in H2O2 treated and hemoglobin overexpressed cells,
compared to H2O2 treated control cells (Fig. 5B).
Discussion
The long-standing perception that hemoglobin is specifically
expressed in erythrocytes has been challenged by recent studies
showing hemoglobin expression in non-erythrocytes including
neurons [24–26], retinal cells [27,28], alveolar cells [29–31],
mesangial cells of the kidney [32], and macrophages [33]. Our
results showed that hemoglobin expression was increased in
NASH (Table 1). Because hemoglobin usually is specifically
expressed in erythrocytes, increased hemoglobin in NASH could
suggest erythropoiesis is induced in NASH livers. During
erythropoiesis, in addition to hemoglobin, other erythrocyte
specific genes such as delta aminolevulinate synthase 2 (ALAS2),
glycophorin A (GYPA), a-a n db-spectrin (SPTA, SPTB), and
hematopoietic transcription factor GATA1 [38,39] should also
be upregulated. But those genes did not show significant
increases in NASH livers. Thus, it is unlikely that the increased
hemoglobin in NASH resulted from erythropoiesis and it raised
Figure 4. Upregulation of hemoglobin expression by oxidative
stress. A, Induction of hemoglobin expression by H2O2 in a dose
dependent manner. HepG2 cells were treated with a series of
concentrations (0, 0.25, 0.5, and 1 mM) of hydrogen proxide (H2O2)
for 8, 16, or 24 hours. Relative HBA1 mRNA levels were determined by
qRT-PCR. Data were expressed as Mean 6 SD (n=3). HBA1 level in
control (0mM, 8hr) was normalized to 1. One way ANOVA and Tukey
post hoc tests for multiple comparisons were used for analyzing the
differences among treatments with different doses. **: p,0.01; ***:
p,0.001, when compared to 0 mM treatment. B, HBA1 proteins were
induced by H2O2 treatment. Whole cell lysates from HepG2 cells treated
with or without H2O2 (1 mM, 48 hours) and blood cells were analyzed
for HBA1 protein. Actin was probed as a loading control. C, HBB mRNA
was upregulated by H2O2 treatment. HepG2 cells were treated with
H2O2 (1 mM) for 48 hours. Reverse transcription PCR products were
separated on 2% agrose gel and visualized with ethidium bromide. D,
HBA1 and HBB mRNA in HEK293 cells were induced by H2O2 treatment.
HEK293 cells were treated with H2O2 (1 mM) for 24 hours and
hemoglobin mRNA levels were determined by qRT-PCR. Hemoglobin
levels in controls were normalized to 1. Data were expressed as Mean 6
SD (n=3).
doi:10.1371/journal.pone.0024363.g004
Figure 5. Reduction of oxidative stress by hemoglobin
overexpression. HepG2 cells were transfected with control or
HBA&HBB expression plasmid for 48 hours and then treated with H2O2
(1 mM, 5 minutes) or mock treated. Intracellular H2O2 levels were
measured by flow cytometry. A, Representative histogram plots of
different treatments. Plots 1 and2:controlandHBA&HBBplasmid without
H2O2 treatment,respectively. Plots3 and4:controlandHBA&HBBplasmid
with H2O2 treatment, respectively. B, Quantitative analysis of mean
fluorescence intensity. Data were expressed as Mean 6 SD (n=4).
doi:10.1371/journal.pone.0024363.g005
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The expression of HBA1 and HBB in hepatocytes was confirmed
on liver biopsies using immunofluorescence staining (Fig. 2).
Hemoglobin expression in human hepatocellular carcinoma
HepG2 cell line (Fig. 3), a commonly used cell line in liver
research, was also observed. This is the first report that
hemoglobin is expressed in hepatocytes.
A recent proteomic study has shown that free hemoglobin a and
b subunits in serum were significantly increased from normal
controls to steatosis and to NASH, suggesting free hemoglobin
subunits in serum could be a biomarker for liver lesions [20]. In
another population study, higher free serum hemoglobin has been
associated with higher prevalence rates of NAFLD [21]. However,
the source of free hemoglobin in serum was not identified. It was
assumed that free hemoglobin in serum was due to oxidative stress
induced hemolysis. Our studies showed that hemoglobin was
expressed in hepatocytes and it was increased in NASH. This
provides a possible explanation for free hemoglobin in serum; free
hemoglobin in serum could have been synthesized in hepatocytes
and then released into the circulatory system. Increased serum free
hemoglobin in NASH could reflect the increased hemoglobin
production in the liver.
Erythropoiesis is a complicate multistep process in which
pluripotent hematopoietic stem cells differentiate into erythrocytes.
Hemoglobin expression is well coordinated and tightly controlled
at the late stage of erythropoiesis. Several transcription factors are
involved in erythroid differentiation. GATA1 is required for
hemoglobin transcription and is also upregulated at the late stage
of erythropoiesis [38,39]. How hemoglobin expression is regulated
in non-erythrocytes is not fully understood. It has been shown
that hypoxia upregulates the transcription of GATA1 in alveolar
epithelial cells. As a result, hemoglobin transcription is also in-
creased by hypoxia [29]. Lipopolysaccharide (LPS) and interferon
(IFN) induce hemoglobin beta expression in mouse macrophages
[33]. Oxidative stress is elevated in NASH and is known to
regulate expression of various genes. Increased hemoglobin
expression could be related to oxidative stress in NASH.
Upregulation of hemoglobin expression by oxidative stress in
HepG2 and HEK293 cells indicated that oxidative stress is an
important regulator for hemoglobin expression in non-erythro-
cytes. Interestingly, our results also showed that oxidative stress
significantly decreased GATA1 expression in HepG2 cells (Fig.
S1), suggesting that, unlike hypoxia, oxidative stress induces
hemoglobin expression via a different mechanism. Transcription
factor Nrf2 is known to be a crucial mediator for oxidative stress
induced gene expression [40]. Further studies are needed to
determine if Nrf2 mediates oxidative stress induced hemoglobin
expression.
The main function of hemoglobin in erythrocytes is to transport
oxygen from the lung to the tissues and to transport carbon
dioxide from the tissues to the lung. Its function in non-
erythrocytes is not clear. It was speculated that the function of
hemoglobin in neurons could be oxygen storage [26]. Hemoglobin
overexpression in mouse dopaminergic cell line resulted in changes
in the expression of various genes involved in oxygen homeostasis
and mitochondrial oxidative phosphorylation [24]. Another study
has shown that in mouse renal mesangial cell line, SV40-MES13,
hemoglobin overexpression reduced oxidative stress, suggesting
hemoglobin functions as an antioxidant [32]. Recently, hemoglo-
bin has been shown to function as an antioxidative peroxidase that
reduces hydrogen peroxide-induced oxidative stress [41]. Consis-
tently, we also showed that hemoglobin overexpression could
suppress hydrogen peroxide-induced oxidative stress in HepG2
cells. Together, our findings suggest that elevated oxidative stress
in NASH could induce hemoglobin expression and suppression of
oxidative stress by hemoglobin could be a mechanism to protect
hepatocytes from oxidative damage.
Materials and Methods
Liver Biopsies
The human studies are approved by the Institutional Review
Board (IRB) of the State University of New York at Buffalo. With
prior written consent from parents, liver biopsies were obtained,
from patients suspected of having NASH as part of regular
medical care. Patients from 7 to 18 years of age signed an assent to
the research. All NASH patients had normal apha-1-antitrypsin
levels, none were phenotype ZZ, and PAS staining of the biopsies
was negative. All had normal or low ferritin and iron levels and
soluble transferring receptor results were not consistent with iron
overload. None of the liver biopsies had histological evidence of
iron. None had any identifiable infectious agent including
Hepatitis A, B, and C. All had normal serum copper and
ceruloplasmin and all had normal celiac screens.
Cell Culture
Human hepatocellular carcinorma HepG2 and embryonic
kidney HEK293 cell lines were obtained from the American
Type Culture Collection and were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) at 37uC under 5% CO2.
Microarray Analysis
Recently published microarry data including 12 NASH and 5
control samples was analyzed to identify differentially expressed
genes in NASH [42,43]. Total RNA of non-NASH controls was
purchased from Admet Technologies (Durham, NC). The
characteristics of NASH and controls were shown in Table 2.
The original dataset has been uploaded to Gene Expression
Omnibus (GEO; website: http://www.ncbi.nlm.nih.gov/gds).
GEO accession number for the dataset is GSE24807.
Quantitative Real Time PCR (qRT-PCR)
Total RNA was extracted from liver biopsies or cells using the
RNeasy Mini Kit from Qiagen. Five hundred nanograms of total
RNA was reverse transcribed to cDNA in 20 ml reaction using the
iScript cDNA Synthesis Kit from Bio-Rad. One ml of the resulting
cDNA was used in a total volume of 50 ml of PCR reaction. Real
time PCR was performed on MyiQ PCR Detection System (Bio-
Rad) using SYBR Green Supermix reagents. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as internal control.
Relative gene expression was calculated as previously described
[42,43]. The following primers were used for qRT-PCR.
Table 2. Characteristics of NASH and Control Groups.
NASH (N=12) Control (N=5)
Sex F3:M9 F1:M4
Age (years) 13.962.7 (9–19) 10.466.1 (5–19)
BMI 32.467.1 (22–45) NA
IR (HOMA) 4.262.4 (1.0–8.4) NA
BMI: Body Mass Index; IR: Insulin Resistance;
HOMA: Homeostasis Model Assessment; NA: Not available.
doi:10.1371/journal.pone.0024363.t002
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GAPDH reverse: 59 ATGGACTGTGGTCATGAGTCCTT 39;
HBA1 forward: 59 ACCCGGTCAACTTCAAGC 39;
HBA1 reverse: 59 AACGGTATTTGGAGGTCAGC 39;
HBB forward: 59 CTCGGTGCCTTTAGTGATGG 39;
HBB reverse: 59 ACACAGACCAGCACGTTG 39.
Immunofluorescence Staining
Liver biopsies were fixed in 4% formaldehyde for 15 minutes at
room temperature and then washed twice with TBS. Fixed
biopsies were transferred to 30% sucrose and kept at 4uC
overnight. Biopsies were then embedded in OCT compound in
cryomolds. Twenty micro meters of cryosections were made on a
cryostat machine and stored at 280uC until staining. Frozen
sections were incubated in PBS for 15 minutes, followed by
permeabilization with 0.75% triton X-100 for 15 minutes and
antigen retrieval in 1% sodium dodecyl sulfate (SDS) for 5
minutes. Sections were incubated with HBA1, HBB, or radixin
antibody (5 ng/ml) for 90 minutes and then blocked with 4% BSA
for 30 minutes. Second antibody conjugated with Alexa 568 or
Alexa 488 (2 ng/ml) was incubated with the sections for 45
minutes. Coverslips were mounted onto sections using mounting
reagent containing 4,6-diamidino-2-phenylindole (DAPI). Immu-
nofluorescence images were recorded under LSM510 beta laser
scanning microscope (Zeiss) using same instrument settings for all
samples.
Plasmid Transfection
HepG2 cells were transfected with a control plasmid or pIRES/
HBA&HBB [32] (Kind gift from Dr. Masaomi Nangaku,
University of Tokyo School of Medicine) using GenJet transfection
reagents (SignaGen), according to manufacturer’s instructions.
Forty eight hours after transfection, cells were harvested for
western blot analysis or used for flow cytometry.
Western Blot Analysis
Whole cell lysates from HepG2 cells were made in SDS lysis
buffer. Protein concentrations were measured using a modified
Bradford method [44]. Sixty mg of whole cell lysates were
separated by 15% SDS polyacrylamide gel electrophoresis and
transferred onto nitrocellulose membrane. After blocking with 5%
milk for 30 min, the membrane was incubated with primary
antibody for 2 hours and then washed three times, followed by
incubation with horseradish peroxidase-conjugated secondary
antibody for 1 hour. After washing three times, the protein bands
were visualized using ECL reagents (Pierce). The images were
recorded with a Fuji Image Reader LAS-1000. HBA1 and HBB
antibodies were purchased from Santa Cruz. Beta actin antibody
was obtained from MP Biomedicals.
Detection of oxidative stress by flow cytometry
Oxidative stress was measured according to a published method
[32]. Briefly, HepG2 cells were washed with PBS and then
incubated with 10 mM of 5-(and-6)-chloromethyl-29,79-dichloro-
dihydroflurescein diacetate, acetyl ester (CM-H2DCFDA; Invitro-
gen) in the dark for 30 minutes at 37uC. After washing with PBS,
HepG2 cells were treated with 1 mM H2O2 for 5 min or left
without treatment, followed by harvesting the cells by trypsin. The
CM-H2DCFDA fluorescence signals were collected immediately
in the FL-1 (530 nm) channel on a FACScalibur machine (Becton
Dickinson). Mean fluorescence intensity (MFI) was analyzed by the
CELL Quest Pro software.
Statistic Analysis
Unpaired student t tests were performed to analyze the
differences between control and experiment groups. One way
ANOVA and Tukey post hoc tests for multiple comparisons were
used for analyzing the differences among H2O2 treatments with
different doses. A p value less than 0.05 was considered to be
statistically significant.
Supporting Information
Figure S1 Down regulation of GATA1 expression by oxidative
stress. Control (0 mM) and H2O2 treated (1 mM) samples were
same as those used in Figure 4A. Relative GATA1 mRNA levels
were determined by RT-PCR. Data represents Mean 6 SD for
three RT-PCR reactions. Compared to control, H2O2 treatment
for 8, 16, or 24 hours significantly decreased the GATA1 mRNA
levels (t test, p,0.05).
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